CPRD Feasibility Tool
Details
- Published
- 19 October 2026
- Submission
- 19 November 2026in 3 weeks
- Source
- uk:atamis:dhsc
Tender description
The requirement is for a white-labelled feasibility and population analytics platform, deployed within CPRD-managed Microsoft Azure infrastructure and operating exclusively against CPRD datasets formatted in the OMOP Common Data Model. The proposed solution must natively support the OMOP Common Data Model and should not require material restructuring, remodelling or transformation of CPRD OMOP datasets to operate. The platform must enable CPRD staff and CPRD-approved external client to conduct self-service feasibility studies and descriptive epidemiological analyses without requiring supplier intervention
Timeline
- Completed: Tender published19 October 2026Current notice
- Next: Submission date19 November 2026in 3 weeks
About the buyer
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components, buying as a central healthcare organisation with its own commercial team.
A rolling commercial pipeline lists larger opportunities due over the next 18 months.
Over the past 5 years, most of Medicines and Healthcare products Regulatory Agency's contract awards have been in business services, IT services and laboratory and precision equipment.
Related topics
Topics related to CPRD Feasibility Tool, ranked by notice volume.
- 1,960£8.0bn
- 3,532£14.5bn
Related buyers
Buyers similar to Medicines and Healthcare products Regulatory Agency.
- 3,062£734.1m
- 1,892£371.9bn
- 1,225£14.3bn
- 791£8.9bn
- 552£22.5bn
- 494£3.5bn
- 440£129.3m
- 389£423.7m
- 356£1.7m
- 322£339.7m
Finding public sector work shouldn't be hard
Make your next tender search effortless with Stotles. Set up alerts, find decision maker contacts and never miss a good-fit opportunity again.